Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ARENA PHARMACEUTICALS, INC
08/09 ARENA PHARMACEUTICALS : Reports Q2 Loss, Updates Pipeline Status
08/08 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) reported earnings of ($0.77) per sha..
08/07 ARENA PHARMACEUTICALS : reports 2Q loss
08/07 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Results of Operations a..
08/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Second Quarter 201..
07/31 ARENA PHARMACEUTICALS : to Release Second Quarter 2017 Financial Results and Pro..
07/31 ARENA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to Purch..
07/13 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Other Events
07/13 ARENA PHARMACEUTICALS : Announces Prospectus To Sell $150 Million In Stock
07/13 ARENA PHARMACEUTICALS : Pulmonary Arterial Hypertension Drug Shows Positive Resu..
07/13 ARENA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
07/12 ARENA PHARMACEUTICALS : Biotech company`s stock jumps 40% on promising drug to t..
07/11 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Results of Operations a..
07/11 ARENA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
07/11 HERE’S WHY ARENA PHARMACEUTICA : ARNA) Is Gaining Strength Today
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
08/10 ARENA PHARMACEUTICALS : Announces Full Exercise of Underwriters' Option to Purch..
08/09 ARENA PHARMACEUTICALS : Reports Q2 Loss, Updates Pipeline Status
08/08 ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
08/08 ARENA PHARMACEUTICALS, INC. : Today's Research Reports on Trending Tickers: Aren..
08/08 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) reported earnings of ($0.77) per sha..
08/07 ARENA PHARMACEUTICALS : reports 2Q loss
08/07 ARENA PHARMACEUTICALS, INC. (NASDAQ : ARNA) Files An 8-K Results of Operations a..
08/07 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Finan..
08/07 ARENA PHARMACEUTICALS : Provides Corporate Update and Reports Second Quarter 201..
08/07 ARENA PHARMACEUTICALS, INC. : Investor Network: Arena Pharmaceuticals, Inc. to H..
More news
Sector news : Biotechnology & Medical Research - NEC
08/15 Three CEOs resign from Trump council over Charlottesville
08/14DJHot Stocks to Watch in the U.S. and Canada
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
07/31 France's Sanofi raises earnings forecast, pleased with eczema drug uptake
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/22 Arena Pharmaceuticals (ARNA) Presents At JMP Securities Life Sciences Confere..
06/21 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi Presents at JMP Securities Life..
06/20 Arena continues up move, shares ahead 25% in three days
06/19 DRYSHIPS : Rank #1 As Worst Stock In Nasdaq
06/17 Stocks to watch next week
06/15 PREMARKET LOSERS AS OF 9 : 05 am
Latest Tweets
08/14Arena Pharmaceuticals, Inc. $ARNA Expected to Post Quarterly Sales of $4.39 M.. 
08/09Arena Pharmaceuticals (ARNA) Q2 Loss Wider than Expected -  
08/08$ARNA New SEC Document(s) for Arena Pharmaceuticals, Inc. From our Stock News.. 
08/08Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 20.. 
08/07$ARNA New SEC Document(s) for Arena Pharmaceuticals, Inc. From our Stock News.. 
More tweets
Qtime:110
Financials ($)
Sales 2017 24,0 M
EBIT 2017 -84,2 M
Net income 2017 -90,5 M
Finance 2017 24,3 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 33,8x
EV / Sales 2018 36,4x
Capitalization 834 M
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | US0400471027 | 4-Traders
Technical analysis trends ARENA PHARMACEUTICALS, INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 37,0 $
Spread / Average Target 74%
EPS Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS, INC.14.01%834
INCYTE CORPORATION26.03%25 995
QUINTILES IMS HOLDINGS INC18.33%19 819
LONZA GROUP37.66%17 539
CELLTRION, INC.--.--%11 245
ALKERMES PLC-7.12%7 929